← All Investors
REPLIGEN CORP
RGEN 1 12-15-28
Holders
2
Combined Value
$13M
Combined Shares
13,997,000
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Howard Marks - Oaktree Capital | $8M | 0.14% | ~$1.02 | — | Sold Q1 2026 | Q1 2026 |
| Steve Cohen - Point72 | $4M | 0.01% | ~$0.98 | — | Bought Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Steve Cohen - Point72 | NEW BUY | +$4M | ~$0.98 |
| Q1 2026 | Howard Marks - Oaktree Capital | SELL | −$813K | ~$0.98 |
| Q4 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$12M | ~$1.01 |
| Q4 2025 | Howard Marks - Oaktree Capital | BUY | +$1M | ~$1.10 |
| Q3 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$12M | ~$1.01 |
| Q3 2025 | Howard Marks - Oaktree Capital | BUY | +$3M | ~$1.01 |
| Q2 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$5M | ~$0.98 |
| Q2 2025 | Howard Marks - Oaktree Capital | BUY | +$3M | ~$1.00 |
| Q1 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$5M | ~$0.98 |
| Q4 2024 | Howard Marks - Oaktree Capital | NEW BUY | +$2M | ~$1.02 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 13,997,000 | +42.4% | $13M | $0.98 |
| Q4 2025 | 1 | 9,830,000 | −52.6% | $10M | $1.10 |
| Q3 2025 | 2 | 20,747,000 | +258.0% | $20M | $1.01 |
| Q2 2025 | 1 | 5,796,000 | −29.3% | $5M | $1.00 |
| Q1 2025 | 2 | 8,200,000 | +272.7% | $8M | $0.98 |
| Q4 2024 | 1 | 2,200,000 | — | $2M | $1.02 |